InPharmX Inc., DBA University Learning Systems Phone: 1-800-940-5860 Email: info@universitylearning.com
Professional learning online at a desk
← All on demand pharmacology CE/CME

On demand pharmacology CE/CME

Theraputic Update - Key West

FormatSelf-paced onlineRecordedApril 28, 2026AccessAvailable now
Log in to register

About this course

Learn at your own pace.

  • This course provides 15 contact hours  of pharmacy CE and  (1.5 CEU) of live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/CME credit.

  • 15.00 Hours Live AAFP Prescribed credit

  • Recorded in Key West on April of 2026

  • Term of Approval is from 04/28/2026 to 12/31/2026

Educational information

Designed for meaningful, practical learning.

Sessions

Session
2026-04-28 New Drug Update Part 1

Tuesday, April 28, 2026

Speaker: Dr. C. Wayne Weart Credit hours: 5 ACPE UAN: 0741-0000-26-006-H01-P

Learning objectives
  1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.
  2. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
  3. Describe their adverse effects and drug interaction that may affect patient compliance.
  4. Compare efficacy, dosage and cost to existing agents.
  5. Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to rec-
  6. Compare pharmacotherapy outcomes vs cost/benefit between newly ap-proved agents and existing or lower cost agents.
2026-04-29 New Drug Update Part 2

Wednesday, April 29, 2026

Speaker: Dr. C. Wayne Weart Credit hours: 5 ACPE UAN: 0741-0000-26-007-H01-P

Learning objectives
  1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.
  2. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
  3. Describe their adverse effects and drug interaction that may affect patient compliance.
  4. Compare efficacy, dosage and cost to existing agents.
  5. Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to rec-
  6. Compare pharmacotherapy outcomes vs cost/benefit between newly ap-proved agents and existing or lower cost agents.
2026-04-30 The Art of Deprescribing in People with Profound Autism

Thursday, April 30, 2026

Speaker: Dr. Michael Cummings Credit hours: 5 ACPE UAN: 0741-0000-26-008-H01-P

Learning objectives
  1. Discuss why individuals with profound autism have reduced access to inpatient psychiatric hospitalization.
  2. Define polypharmacy.
  3. Identify three reasons for polypharmacy in people with profound autism.
  4. Apply deprescribing strategies to a clinical case example.
  5. Define diagnostic overshadowing and evaluate factors that may contribute to it using a clinical case example.
  6. Identify three common psychotropic side effects and assess how they contribute to aggression and self-injurious behaviors in people with intellectual disabilities.
  7. Distinguish between affective and mood lability and describe how those differences influence treatment planning.
  8. Describe the diagnostic and treatment differences of catatonia in people with and without an intellectual disability
  9. Formulate a treatment plan for an individual with profound autism and excited catatonia.

Faculty

Portrait of Dr. C. Wayne Weart, ULS faculty member

Dr. C. Wayne Weart, PharmD, BCPS, FASHP

Professor Emeritus of Family Medicine and Clinical Pharmacy · Medical University of South Carolina

A distinguished clinical pharmacy educator whose teaching connects new-drug evidence, therapeutics, outcomes, and practical family-medicine care.

Professional profile ↗
Portrait of Dr. Michael Cummings, ULS faculty member

Dr. Michael Cummings, MD

Vice Chair and Assistant Professor of Psychiatry · University at Buffalo

A psychiatrist and educator in the Jacobs School of Medicine and Biomedical Sciences whose clinical teaching includes complex behavioral health and deprescribing.

Professional profile ↗

Accreditation

Target audience

Pharmacists, Nurse Practitioners, Physicians, Physician Assistants, Nurses

PHARMACISTS

  • University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. 
  • These programs are accredited for all pharmacists.
  • This course provides 15 hours or 1.5 CEUs.
  • Credit for this course expires on April 28, 2029.

PHYSICIANS

The American Academy of Family Physicians (AAFP) has reviewed Theraputic Update - Key West and deemed it acceptable for up to 15 Live AAFP Prescribed credit(s). Term of Approval is from April 28, 2026 to April 28, 2026 Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s) toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Osteopathic Association (AOA).‍ ‍ Continuing medical education (CME) activities approved for American Academy of Family Physicians (AAFP) credit are recognized by the American Osteopathic Association (AOA) as equivalent to AOA Category 2 credit. 

NURSES

  • This course provides 15 hours (1.5 CEU)
  • University Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357:
  • University Learning Systems is approved by CE Broker for Florida, Georgia, Arkansas, District of Columbia, Georgia, New Mexico, and West Virginia, Boards of Nursing. 
  • The same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.

OTHER PROFESSIONS

  • CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

  • CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). 

  • CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians

  • Other healthcare professionals should confirm acceptance and reporting requirements with their licensing or certification board

Requirements and reporting

  • University Learning Systems reports pharmacy credit through CPE Monitor using the participant’s eNABPID number and date of birth.
  • University Learning Systems is approved by CE Broker, for pharmacy, medicine and nursing for participating states,  Tracking #50-11357. Participant's state license number is required for reporting.
  • Credit is based on completed evaluations for registered sessions. 
  • Credit is awarded per session; partial session credit is not available, and breaks are excluded.
  • Other eligible participants receive an applicable statement of credit after completing the required documentation.

Review complete ULS accreditation statements →

Course fees

DescriptionPrice
Default 15 Hours$250

Begin today

Ready when you are.

Log in to register